{
    "clinical_study": {
        "@rank": "110883", 
        "arm_group": {
            "arm_group_label": "ranibizumab", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "In the prospective monocentric open label trial patients with diabetic macular edema will be\n      treated with intravitreal injections of ranibizumab given for 3 months then with laser grid\n      at month 4. During follow-up a ranibizumab injection will be performed every 2 months in\n      case of best-corrected visual acuity decreased more than 5 letters."
        }, 
        "brief_title": "Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment", 
        "condition": "Diabetic Macular Edema", 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Macular Edema", 
                "Vision Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diabetes mellitus (1 or2)\n\n          -  decreased vision from Diabetic Macular Edema (study eye Best Corrected Visual\n             Acuity<69 letters using E.T.D.R.S testing)\n\n          -  macular edema\n\n        Exclusion Criteria:\n\n          -  history of severe cardiac disease\n\n          -  stroke within 12 months\n\n          -  intraocular inflammation"
            }, 
            "gender": "Both", 
            "maximum_age": "79 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "March 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823965", 
            "org_study_id": "LLOMD"
        }, 
        "intervention": {
            "arm_group_label": "ranibizumab", 
            "intervention_name": "ranibizumab", 
            "intervention_type": "Drug"
        }, 
        "lastchanged_date": "April 3, 2013", 
        "location": {
            "contact": {
                "email": "katia.gourou@chu-poitiers.fr", 
                "last_name": "KATIA GOUROU", 
                "phone": "0549443283"
            }, 
            "facility": {
                "address": {
                    "city": "Poitiers", 
                    "country": "France", 
                    "zip": "86021"
                }, 
                "name": "Chu de Poitiers"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "overall_contact": {
            "email": "michele.boissonnot@chu-poitiers.fr", 
            "last_name": "michele BOISSONNOT", 
            "phone": "0549444891"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of intravitreal injections of ranibizumab", 
            "time_frame": "1 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823965"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "best-corrected visual acuity", 
            "time_frame": "1 years"
        }, 
        "source": "Poitiers University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Poitiers University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}